Ondine Biomedical Listed by incransom Ransomware Group: Ransomware Claim — What’s Alleged & What To Do
Ondine Biomedical was listed by the incransom ransomware group on February 16, 2026, after internal files were exfiltrated in an attack. People whose data may have been exposed should check the company’s notices and monitor their accounts for unusual activity.
On February 16, 2026, the ransomware group incransom listed Ondine Biomedical on its leak site, claiming to have obtained internal files from the Canadian company. The number of individuals whose information may be involved remains unknown, and the company has not confirmed the incident or the extent of any data exposure.
The listing states that the group will publish additional details the following week. At present, no independent verification of the claimed exfiltration has been made public, leaving affected individuals without confirmed information about what records, if any, may have left the organisation.
What happened
Ondine Biomedical was listed by the incransom ransomware group on February 16, 2026. The group claims that internal files were exfiltrated during a ransomware attack. No figure for the volume of data or the number of people potentially affected has been disclosed. The company has not issued a public statement confirming or denying the claims.
The group indicated it would release further information the week after the listing. Beyond the assertion that files were taken, specific details about the method of access, the duration of any intrusion, or whether encryption was also deployed have not been made public.
The group behind it: incransom
Incransom is a ransomware operation that uses a double-extortion model: it exfiltrates data before encrypting systems and then lists victims on a public leak site to pressure payment. The group has previously posted claims involving organisations in multiple sectors, typically asserting possession of internal documents, credentials, or operational records.
Listings by the group constitute an unverified claim by the threat actor. In past incidents, incransom has released portions of claimed data when demands were not met, though the authenticity and completeness of such releases vary. No confirmation exists that the files referenced in the Ondine listing have been or will be shared beyond the initial announcement.
About Ondine Biomedical
Ondine Biomedical is a Canadian company headquartered in Canada and led by founder and chief executive Carolyn Cross. It develops a photodisinfection technology platform intended for the treatment and prevention of infections, including those caused by multidrug-resistant pathogens. The technology is not currently approved for use in the United States.
Organisations in this sector routinely hold research records, regulatory correspondence, clinical trial data, intellectual-property documentation, and information about partners or trial participants. A breach at such a firm can therefore touch both commercial information and records that identify individuals involved in medical or research activities.
The information in question
The only data type named in the listing is internal files exfiltrated during a ransomware attack. No further categories—such as employee records, patient data, financial information, or research files—have been specified by either the group or the company.
Because the exact contents remain undisclosed, it is not possible to state which records, if any, contain personal information. Organisations of this type commonly store data on staff, clinical collaborators, and research subjects, but whether any of those categories were among the claimed files is unconfirmed.
Why it matters
Internal files from a medical-technology company can include proprietary research, regulatory submissions, and operational details whose exposure may affect competitive position or future approvals. Where personal information is present, individuals could face risks of targeted fraud or unwanted contact, though the scale of any such exposure is not yet known.
For the organisation, the incident adds to the operational burden of investigating the claim, notifying regulators if required, and managing any downstream consequences for research or commercial relationships. The absence of Reported Details limits the ability of affected people to assess their own exposure.
If your data was in this claimed breach
Monitor official statements from Ondine Biomedical and any regulatory notices that may follow. Change passwords for any accounts associated with the company and enable multi-factor authentication where available. Watch for unusual activity on financial or medical accounts.
Readers can run a free exposure scan of their email address against known breach data to check whether their information appears in previously published datasets from other incidents.
AICompiled with AI assistance from public sources and published under our editorial standards.
How this breach connects
More recent breaches
Aesthetic Surgical Images Listed by incransom Ransomware GroupColorado Rehabilitation & Occupational Medicine Claimed by IncRansomhamilton-eye.com Listed by incransom Ransomware GroupLife Bridges Non-Profit Claimed by Incransom RansomwareLatest breaches
Read GalaxyWarden’s full analysis of the Ondine Biomedical Listed by incransom Ransomware Group →
Publicly posted by incransom — unverified claim, pending independent verification
Breach listings — particularly those originating from ransomware or leak sites — are third-party claims that may be unverified, incomplete, or inaccurate. A listing does not by itself confirm that a breach occurred or that any specific data was exposed. Severity is an automated assessment, not a definitive rating. Verification status is shown where available.
Attributions to threat groups and methods reflect public reporting and, in some cases, unverified claims made by the groups themselves; they may be incomplete or later revised. Recent Breaches and GalaxyWarden are independent and are not affiliated with, and do not endorse, any company or group named on this page. This information is aggregated from public sources for awareness only and is not legal, security, or investment advice.